Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 18/06/21 → 31/12/24 |
Keywords
- Lung diseases
- Pulmonary fibrosis
- Clinical trial
Clinical Trial Phase
- Phase II
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis
- Glaspole, Ian (Primary Chief Investigator (PCI))
- Symons, Karen (Project Manager)
Project: Research